Free Trial

Canaccord Genuity Group Cuts Canopy Growth (TSE:WEED) Price Target to C$1.50

Canopy Growth logo with Medical background

Canopy Growth (TSE:WEED - Get Free Report) had its target price lowered by equities research analysts at Canaccord Genuity Group from C$2.50 to C$1.50 in a research note issued on Monday,BayStreet.CA reports. The firm presently has a "sell" rating on the stock. Canaccord Genuity Group's price objective indicates a potential downside of 44.03% from the stock's previous close.

Separately, ATB Capital lowered Canopy Growth from a "sector perform" rating to an "underperform" rating and lowered their price objective for the stock from C$6.00 to C$4.00 in a research report on Tuesday, December 17th. Four research analysts have rated the stock with a sell rating and one has issued a hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Reduce" and a consensus target price of C$5.40.

Get Our Latest Stock Report on Canopy Growth

Canopy Growth Trading Up 4.7 %

TSE WEED traded up C$0.12 on Monday, reaching C$2.68. The company had a trading volume of 1,278,250 shares, compared to its average volume of 1,873,167. Canopy Growth has a fifty-two week low of C$2.50 and a fifty-two week high of C$20.50. The company has a debt-to-equity ratio of 120.38, a current ratio of 1.39 and a quick ratio of 2.32. The firm has a market cap of C$431.13 million, a price-to-earnings ratio of -0.39, a P/E/G ratio of -0.01 and a beta of 1.79. The business has a 50 day moving average of C$3.72 and a two-hundred day moving average of C$5.84.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Recommended Stories

Analyst Recommendations for Canopy Growth (TSE:WEED)

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a "Strong Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines